Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262990
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2005-12-06
Brief Title:
Patupilone Versus Doxorubicin in Patients With Ovarian Primary Fallopian or Peritoneal Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Peritoneal Neoplasms |
| Ovarian Cancer |
| Fallopian Tube Cancer |